Scholarly Index
Izumi Sato
Eli Lilly (Japan); 1,089 total citations; 90 total publications; best world rank #120
Eli Lilly (Japan)
1,089Total citations
90Total publications
14H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Neurological and metabolic disorders | 2021-2025 | 120 | JP 14 | 77.78 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 241 | JP 42 | 69.19 |
| Alcoholism and Thiamine Deficiency | 2021-2025 | 140 | JP 5 | 71.08 |